Treatment for Intestinal Tuberculosis

First-Line Treatment Regimen

The standard treatment for intestinal tuberculosis is a 6-month regimen consisting of isoniazid, rifampin, pyrazinamide, and ethambutol for the first 2 months, followed by isoniazid and rifampin for an additional 4 months, as recommended by the American College of Physicians 1
Initial phase (first 2 months): Daily isoniazid, rifampin, pyrazinamide, and ethambutol, with a strength of evidence based on clinical guidelines 1
Continuation phase (next 4 months): Daily isoniazid and rifampin, with a cure rate comparable to longer regimens 1

For isoniazid-resistant TB: Add a later-generation fluoroquinolone to a 6-month regimen of daily rifampin, ethambutol, and pyrazinamide, as recommended by the American Thoracic Society 2, 3
For MDR/RR-TB with extrapulmonary involvement: A 6-month BPaLM regimen (bedaquiline, pretomanid, linezolid, moxifloxacin) is recommended for extrapulmonary TB including intestinal TB, with a strength of evidence based on recent clinical trials 4

Treatment should be extended to at least 9 months and for at least 6 months beyond documented culture conversion for patients with HIV and intestinal TB, as recommended by the Centers for Disease Control and Prevention 1

Regular clinical assessment for symptom improvement (abdominal pain, fever, weight gain) is recommended, with a strength of evidence based on clinical guidelines 1
Directly observed therapy (DOT) is strongly recommended to ensure adherence, as recommended by the World Health Organization 1

Surgical intervention should be considered only for complications such as intestinal obstruction, perforation, or diagnostic uncertainty, as recommended by the American College of Surgeons 1